Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.21.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Computation of earnings per share
                               
    Three Months Ended September 30,     Six Months Ended September 30,  
(In thousands, except per share data)   2021     2020     2021     2020  
Numerator:                        
Income (loss) from continuing operations   $ (100 )   $ 151     $ (1,198 )   $ (557 )
Income (loss) from discontinued operations           (31 )           917  
Net income (loss)   $ (100 )   $ 120     $ (1,198 )   $ 360  
                                 
Denominator:                                
Weighted-average number of common shares outstanding: basic     2,344       2,008       2,219       1,924  
Dilutive effect of stock options           149             192  
Dilutive effect of restricted stock           2             2  
Weighted-average number of common shares outstanding: diluted     2,344       2,159       2,219       2,118  
                                 
Income (loss) per share from continuing operations   $ (0.04 )   $ 0.08     $ (0.54 )   $ (0.29 )
Income (loss) per share from discontinued operations           (0.02 )           0.48  
Net income (loss) per share: basic   $ (0.04 )   $ 0.06     $ (0.54 )   $ 0.19  
                                 
Income (loss) per share from continuing operations   $ (0.04 )   $ 0.07     $ (0.54 )   $ (0.26 )
Income (loss) per share from discontinued operations           (0.01 )           0.43  
Net income (loss) per share: diluted   $ (0.04 )   $ 0.06     $ (0.54 )   $ 0.17  
Schedule of antidilutive shares
                               
    Three Months Ended September 30,     Six Months Ended September 30,  
(In thousands)   2021     2020     2021     2020  
Stock options     207       65       207       75  
Restricted stock           2             2  
Warrants     106       150       106       150  
Common stock units (1)     46       46       46       46  
      359       263       359       273  

 

(1) Consists of 30,668 restricted stock units and warrants to purchase 15,332 shares of common stock
Disaggregated Revenue by Source
                               
(In thousands)   Three Months Ended September 30,     Six Months Ended September 30,  
Product   2021     2020     2021     2020  
Human Care     2,591       4,776       5,186       10,094  
Animal Care     1,005       951       1,937       1,388  
Service and Royalty     148       42       305       54  
      3,744       5,769       7,428       11,536